- Home
- SCKT vs GLMD Comparison
SCKT vs GLMD Comparison
Compare SCKT & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- GLMD
- Stock Information
- Founded
- SCKT 1992
- GLMD 2000
- Country
- SCKT United States
- GLMD Israel
- Employees
- SCKT N/A
- GLMD N/A
- Industry
- SCKT Computer Manufacturing
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- GLMD Health Care
- Exchange
- SCKT Nasdaq
- GLMD Nasdaq
- Market Cap
- SCKT 9.8M
- GLMD 8.1M
- IPO Year
- SCKT 1995
- GLMD 2014
- Fundamental
- Price
- SCKT $1.05
- GLMD $1.28
- Analyst Decision
- SCKT
- GLMD Hold
- Analyst Count
- SCKT 0
- GLMD 1
- Target Price
- SCKT N/A
- GLMD N/A
- AVG Volume (30 Days)
- SCKT 17.0K
- GLMD 220.9K
- Earning Date
- SCKT 10-23-2025
- GLMD 08-28-2025
- Dividend Yield
- SCKT N/A
- GLMD N/A
- EPS Growth
- SCKT N/A
- GLMD N/A
- EPS
- SCKT N/A
- GLMD N/A
- Revenue
- SCKT $16,710,984.00
- GLMD N/A
- Revenue This Year
- SCKT $8.62
- GLMD N/A
- Revenue Next Year
- SCKT N/A
- GLMD N/A
- P/E Ratio
- SCKT N/A
- GLMD N/A
- Revenue Growth
- SCKT N/A
- GLMD N/A
- 52 Week Low
- SCKT $0.85
- GLMD $1.15
- 52 Week High
- SCKT $1.72
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- SCKT 48.49
- GLMD 35.31
- Support Level
- SCKT $1.01
- GLMD $1.33
- Resistance Level
- SCKT $1.09
- GLMD $1.63
- Average True Range (ATR)
- SCKT 0.06
- GLMD 0.11
- MACD
- SCKT 0.01
- GLMD -0.01
- Stochastic Oscillator
- SCKT 80.04
- GLMD 10.26
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.